Relyens Innovation Santé

Investor profile | Builders Republic

About

Relyens Innovation Santé is the venture capital firm of the European mutual group Relyens, the insurer for healthcare professionals, formerly Sham, based in Lyon. Founded in 2014, it has been advised since its inception by Turenne Santé, the healthcare team of the Turenne group, which often co-invests alongside it. It provides long-term funding to digital health, medical device, and biotechnology companies addressing unmet medical needs. Around twenty startups have been funded, and the sale of PathoQuest to Charles River Laboratories in April 2026 marked its tenth exit. The portfolio includes Carthera, Mablink Bioscience, Coave Therapeutics, Cairdac, Therapixel, Pixee Medical, DeepLife, Kimialys, BrainEver, and Citalid. For a health startup seeking an investor backed by a healthcare institution insurer, it is a shareholder closely connected to the hospital field.

Key facts

Type
Corporate VC
Stages
Seed,Series A,Series B
Sectors
Healthcare,Diagnostics,Digital health,Biotech,Medtech
Headquarters
France
Offices
Lyon
Geographic focus
France
Founded
2014

Track record

  • Portfolio companies: 20
  • Exits: 10

Notable investments

DeepLife, AlgoTx, Therapixel, Domain Therapeutics, Germitec, BrainEver

Funds by stage

Other funds investing at the same stages, list by list.

Funds by sector

The funds investing in each sector, based on their rounds over the last 36 months.